相关实验视频
Updated: Jul 5, 2026

06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
9.5K
塞沃弗兰和普罗波通过调节TM2D1共同影响结肠直肠癌的发展
Yan Lu1, Ling Li1, Zongfang Piao2
1Department of Anesthesiology, Affiliated Hospital of Chengde Medical University, Chengde City, 067000, P.R. China.
Combinatorial chemistry & high throughput screening
|June 26, 2024
概括
塞沃弗兰和普罗波通过诱导亡和铁亡,在结直肠癌中表现出抗瘤作用. 向TM2D1可能为结直肠癌患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 麻醉学 麻醉学
- 分子生物学分子生物学
背景情况:
- 塞沃弗兰和普罗波是广泛使用的麻醉剂.
- 它们在结直肠癌中的作用需要进一步阐明.
研究的目的:
- 为了研究sevoflurane和propofol在结直肠癌中的抗瘤功能.
- 探索它们的潜在分子机制.
主要方法:
- 在体外测试包括细胞计数套件-8,殖民地形成,西部污染和跨井测试.
- 过度表达实验以确定分子目标.
- 对表皮层-介质细胞过渡 (EMT) 标记物的分析.
主要成果:
- 与单个治疗相比,合并的佛和普罗波显示出增强的抗瘤活性.
- 这些麻醉剂诱导了亡和铁亡,同时抑制了增殖,入侵和迁移.
- TM2D1被确定为标,其过度表达逆转了观察到的抗瘤效应.
结论:
- 塞沃弗兰和普罗波在结直肠癌细胞中具有新的抗瘤机制.
- TM2D1为结直肠癌治疗提供了潜在的治疗点.
相关概念视频
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

